Latest filing published 17 Mar 2021 for Niagen Bioscience, Inc., €52k.
This profile gathers the share dealings of Stephen A. Block across 2 companies, led by Senomyx Inc and Niagen Bioscience, Inc. In total, 20 filings cover trades dated from 9 November 2010 to 16 March 2021.
The open-market record consists of 9 sales worth €872k, with no purchase. Besides market trades, the filings include 1 share grant and 9 option exercises. 2021 to date brings no purchases and 2 sales.
The newest entry dates from 17 March 2021: an open-market sale of €303k, in Niagen Bioscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations